13. Proteomics and Cancer Risk Assessment

  1. Prof. Dr. Günter Obe2,3,
  2. Dr. Burkhard Jandrig4,
  3. Prof. Dr. Gary E. Marchant5,
  4. Dipl. Päd. Holger Schütz6 and
  5. Prof. Dr. Peter M. Wiedemann7
  1. Alexander Schramm

Published Online: 27 APR 2011

DOI: 10.1002/9783527634613.ch13

Cancer Risk Evaluation: Methods and Trends

Cancer Risk Evaluation: Methods and Trends

How to Cite

Schramm, A. (2011) Proteomics and Cancer Risk Assessment, in Cancer Risk Evaluation: Methods and Trends (eds G. Obe, B. Jandrig, G. E. Marchant, H. Schütz and P. M. Wiedemann), Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, Germany. doi: 10.1002/9783527634613.ch13

Editor Information

  1. 2

    Ret. from University Duisburg-Essen, Germany

  2. 3

    Gershwinstrasse 33, 14513 Teltow, Germany

  3. 4

    Max-Delbrück-Center for Molecular Medicine (MDC), Robert-Rössle-Str. 10, 13125 Berlin, Germany

  4. 5

    Arizona State University, Sandra Day O'Connor College of Law, P.O. Box 877906, Tempe, AZ 85287-796, USA

  5. 6

    Research Center Jülich, Institute of Neuroscience and Medicine (INM-8), 52425 Jülich, Germany

  6. 7

    Karlsruher Institut für Technologie (KIT), TAB – Büro für Technikfolgen-Abschätzung beim Deutschen Bundestag, Neue Schönhauser Straße 10, 10178 Berlin, Germany

Author Information

  1. Universitätsklinikum Essen, Pädiatrie III, Onkologisches Labor, Hufelandstr. 55, 45122 Essen, Germany

Publication History

  1. Published Online: 27 APR 2011
  2. Published Print: 20 APR 2011

ISBN Information

Print ISBN: 9783527327539

Online ISBN: 9783527634613



  • electrophoresis;
  • electrospray ionization;
  • liquid chromatography;
  • mass spectrometry;
  • matrix-assisted laser desorption ionization;
  • proteomics


This chapter contains sections titled:

  • Introduction

  • Sample Preparation and Storage: A Challenge in Clinical Settings

  • Caveats and Hurdles in Protein Analysis Using Cancer Specimen and Clinical Samples

  • Separation and Fractionation of Protein Mixtures as a Prerequisite to Proteomic Analyses and Protein Quantification

  • Identification of Proteins by Mass Spectrometry

  • Array-Based Proteome Technology in Cancer Research

  • The Present and the Future: Proteomics for Individualized Cancer Therapy

  • References